There is a new challenge facing the pharma industry with the FGIS MDLP, the Russia serialization regulations, that come into force on 1 January 2020. Their ambitious timeline and strict requirements pose a threat to pharma companies who are already compliant with other traceability regulations as you will need to review these processes to see how they will adhere to the Russia requirements.
If you are part of a supply chain that import into Russia there are several challenges that you need to understand, including a full track-and-trace approach with item level coding and aggregation and a complex reporting system. These requirements will affect your production lines, processes and infrastructure, through the need for a cryptographic approach, an increased data matrix size.
Our webinar on the 12 March will discuss the challenges of exporting into Russia and start you on the right track to securing sales. We will be fully exploring these challenges, sharing our insights as well as outlining critical elements of a Russia readiness programme.
Register at https://register.gotowebinar.com and join us on the 12 March for a round table online webinar to discuss these unique challenges and how to comply with these requirements while maintaining your current traceability processes.